|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910298325403321 |
|
|
Titolo |
Commercial Plant-Produced Recombinant Protein Products : Case Studies / / edited by John A. Howard, Elizabeth E. Hood |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Berlin, Heidelberg : , : Springer Berlin Heidelberg : , : Imprint : Springer, , 2014 |
|
|
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Edizione |
[1st ed. 2014.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (282 p.) |
|
|
|
|
|
|
Collana |
|
Biotechnology in Agriculture and Forestry, , 2512-3696 ; ; 68 |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Plant biotechnology |
Biotechnology |
Pharmaceutical chemistry |
Plant Biotechnology |
Pharmaceutics |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references at the end of each chapters and index. |
|
|
|
|
|
|
|
|
Nota di contenuto |
|
Introduction — Plant-produced protein products -- Commercial Plant-Produced Recombinant Avidin -- Molecular farming in plants – the long road to the market -- TrypZean™: an animal-free alternative to bovine trypsin -- Production of Pharmaceutical Grade Recombinant Native Aprotinin and Non-Oxidized Aprotinin-Variants Under Greenhouse and Field Conditions -- Influenza virus-like particles produced in Nicotiana benthamiana protect against a lethal viral challenge in mice -- Plant-Produced Recombinant Transmission Blocking Vaccine Candidates to Combat Malaria -- An oral vaccine for TGEV immunization of pigs -- Edible Rabies Vaccines -- Newcastle disease vaccines -- An oral vaccine for hepatitis B: challenges, setbacks and breakthroughs -- Commercial Plant-Produced Recombinant Cellulases for Biomass Conversion -- Brazzein: A High Intensity Natural Sweetener -- The Future of Plant-Produced Pharmaceuticals and Industrial Proteins. |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
Attention has recently turned to using plants as hosts for the production of commercially important proteins. The twelve case studies in this volume present successful strategies for using plants to produce industrial and pharmaceutical proteins and vaccine antigens. They |
|
|
|
|